Mammography Screening Frequency in Australia
In Australia, mammography screening is recommended every 2 years for women aged 50-74 years through the national BreastScreen Australia program. 1
Screening Recommendations by Age Group
- For women aged 50-74 years, biennial (every 2 years) mammography screening is the standard recommendation in Australia 1
- Women aged 40-49 years can access the program but are not actively invited to participate in the national screening program 1
- Women aged 75 and older can continue screening but are not actively recruited 2
- The participation rate in the BreastScreen Australia program is approximately 56-60% 1, 3
Special Considerations for Higher Risk Groups
- Women with a family history of breast cancer (having at least one first-degree relative diagnosed with breast cancer) may benefit from annual rather than biennial screening 4
- Annual screening for women with family history has been shown to increase the odds of being diagnosed with smaller, node-negative tumors compared to biennial screening 4
- Women with genetic mutations such as BRCA1 and BRCA2 may require earlier and more frequent screening than the general population 5
Effectiveness of the Australian Screening Program
- Since the introduction of BreastScreen Australia in 1991, there has been a 28% reduction in age-standardized breast cancer mortality 6
- Studies suggest that mammography screening through BreastScreen Australia has contributed to a 21-30% reduction in breast cancer mortality 3
- However, some research indicates that improvements in treatment, particularly adjuvant hormonal and chemotherapy, may account for a significant portion of the mortality reduction 6
Comparison with International Guidelines
- Australian recommendations align closely with Canadian guidelines, which also recommend screening every 2-3 years for women aged 50-74 years 5
- This differs from some American organizations like the American Cancer Society, which recommends annual mammography starting at age 40 7
- The American College of Physicians recommends stopping screening in women aged 75 or older, or those with a life expectancy of less than 10 years 2
Potential Harms and Benefits
- Benefits include reduced breast cancer mortality through early detection 8, 3
- Potential harms include discomfort during examination, anxiety related to false-positive results, and possible overdiagnosis 2, 1
- Overdiagnosis in Australia has been estimated to be as low as 8% of detected cancers, though some research suggests it could be up to 30% 1
Screening Participation Considerations
- Participation rates are lower among Aboriginal and Torres Strait Islander women, women in remote areas, and women with lower socio-economic status 1
- Increased screening participation is associated with greater mortality reduction, with studies showing that achieving the program target of 70% participation could result in a 25-34% reduction in breast cancer mortality 3